LLY receives FDA approval for Lilly's Olumiant.
Eli Lilly and Company（LLY）的 Lilly's Olumiant 获美国 FDA 批准。
For information only. Not investment advice.内容仅供参考，不构成投资建议。
Eli Lilly and Company (LLY) falls 4.34% to $1,137Eli Lilly and Company（LLY）下跌 4.34%，报 $1,137
Stock Price Move · October 8, 2026个股行情异动 · 2026/10/8
Eli Lilly and Company (LLY) rises 4.04% to $1,204Eli Lilly and Company（LLY）上涨 4.04%，报 $1,204
Stock Price Move · October 7, 2026个股行情异动 · 2026/10/7
LLY regulated product launch: Lilly launches the Lilly Change the Course Commitment, aiming to address treatment gaps in diabetes and obesity in LMICsEli Lilly and Company（LLY）正式推出获批药品或治疗产品
Material Company Event · September 28, 2026公司公告 · 2026/9/28
